SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001567619-21-000712
Filing Date
2021-01-07
Accepted
2021-01-07 15:13:04
Documents
1
Period of Report
2021-01-05

Document Format Files

Seq Description Document Type Size
1 FORM 4/A doc1.html 4/A  
1 FORM 4/A doc1.xml 4/A 12997
  Complete submission text file 0001567619-21-000712.txt   14525
Mailing Address 2945 TOWNSGATE ROAD SUITE 110 WESTLAKE VILLAGE CA 91361
Business Address 2945 TOWNSGATE ROAD SUITE 110 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Issuer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARCUTIS BIOTHERAPEUTICS, INC. 2945 TOWNSGATE ROAD, SUITE 110 WESTLAKE VILLAGE CA 91361
Business Address
Watanabe Todd Franklin (Reporting) CIK: 0001801061 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39186 | Film No.: 21514041